CPAP recall and cancer risk: should we be concerned?

Gagnadoux,F.,Bailly,S.,Schwab,R. J.
DOI: https://doi.org/10.1183/13993003.01591-2024
IF: 24.3
2024-11-07
European Respiratory Journal
Abstract:Extract There is an expanding literature on the association between obstructive sleep apnoea (OSA) and cancer risk [1, 2]. Evidence is growing from population- and clinic-based cohort studies that the severity of OSA and sleep-related hypoxaemia may adversely affect both overall cancer risk and incidence of certain cancers [3–7]. These clinical findings are supported by the identification of the intermediate mechanisms by which intermittent hypoxia and sleep fragmentation, the hallmark features of OSA, might promote oncogenesis, tumour growth and metastasis [8]. Although studies have shown a relationship between OSA and cancer, few have evaluated whether the risk of cancer development or progression in patients with OSA is modified by continuous positive airway pressure (CPAP) therapy (the primary treatment for OSA) [1, 2].
respiratory system
What problem does this paper attempt to address?